epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Kytril
    granisetron
  • remove Mucinex Sinus-Max Severe Congestion & Pain
    acetaminophen/ phenylephrine/ guaifenesin
  • remove Qtern
    dapagliflozin/ saxagliptin
  • remove Yorvipath
    palopegteriparatide

multicheck MultiCheck Results - 3 Interactions

Smiley face Smiley face

Monitor/Modify Tx

Smiley face Smiley face Mucinex Sinus-Max Severe Congestion & Pain (acetaminophen/ phenylephrine/ guaifenesin) + Qtern (dapagliflozin/ saxagliptin)

Monitor/Modify Tx


phenylephrine + dapagliflozin

monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

phenylephrine + saxagliptin

monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects)

Smiley face Smiley face Qtern (dapagliflozin/ saxagliptin) + Yorvipath (palopegteriparatide)

Monitor/Modify Tx


dapagliflozin + palopegteriparatide

monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)

Additional Considerations

Smiley face Smiley face phenylephrine in Mucinex Sinus-Max Severe Congestion & Pain

add MAO inhibitor to Interaction Check if recent (14 days) use

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information